SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is experiencing significant volatility and downward pressure as investors weigh recent acquisition activity against broader macroeconomic headwinds, including geopolitical tensions and fluctuating construction market sentiment. Despite the bearish pressure, the community remains actively divided, with many long-term shareholders continuing to express confidence in CEO Brad Jacobs' consolidation strategy while others closely monitor for the next M&A catalyst or integration updates.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility and price appreciation following its recent NYSE listing, with investors actively debating whether the high premium over its reported net asset value is justified by its exclusive exposure to high-profile private AI companies like Anthropic and OpenAI. Community discussion is dominated by the impact of a mandatory six-month lockup period on the majority of shares, which has created a tight float and sparked intense speculation about potential for further momentum or a sharp correction.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

TSLA is under significant downward pressure as investors rotate out of growth stocks amid geopolitical instability and skepticism regarding the execution of its latest AI and infrastructure initiatives. The community remains deeply divided, with some buyers viewing the current price action as a long-term accumulation opportunity, while others express frustration over the stock's recent technical breakdown and the company's dependency on speculative future projects.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is capturing significant market attention as users actively engage with its updated lending protocol, allowing them to borrow against staked SOL while simultaneously participating in its broader ecosystem of meme tokens and community-verified projects. Discussions are currently dominated by high APY lending opportunities and the ongoing expansion of its verified token list, fueling diverse sentiment ranging from strong platform loyalty to speculative debates over its long-term tokenomics.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is generating significant buzz as investors anticipate upcoming fourth-quarter earnings and critical updates regarding the clinical development of its pipeline candidate, aritinercept. The community is actively debating the company's long-term valuation, with many shareholders expressing frustration over management's communication style while simultaneously monitoring potential M&A activity within the broader biotech sector.

Crane Harbor Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on January 2, 2025 and is headquartered in Philadelphia, PA.

Crane Harbor Acquisition Corp. - Ordinary Shares - Class A

Crane Harbor Acquisition Corp.

Crane Harbor Acquisition Corp. is trending as shareholders recently approved its merger with Xanadu Quantum Technologies, a milestone expected to establish the first publicly traded photonic quantum computing company under the ticker XNDU. Community discussion is heavily focused on the deal's potential for a low-float short-term squeeze, strategic partnerships with major tech industry leaders, and potential government funding support.

Harvest Portfolios Group Inc - Harvest Diversified High Income Shares ETF (Class A Units)

Investors are actively debating the merits of Harvest Diversified High Income Shares ETF, frequently highlighting it as a core component for income-focused portfolios and tax-efficient strategies within Canadian tax-advantaged accounts. While some community members view market dips as opportunities for accumulation, others are engaged in broader discussions regarding the performance of its underlying covered call strategy and its role in long-term wealth building.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors digest a massive Q4 booking report that significantly exceeded expectations, signaling robust long-term demand for AI-driven lithography equipment. Community discussion remains heavily focused on the company's unassailable moat as a 'foundational' AI player, with many traders debating the sustainability of current valuation highs despite strong buyback announcements and increased backlog visibility.

ETF Opportunities Trust - T-Rex 2X Inverse MSTR Daily Target ETF

T-Rex 2X Inverse MSTR Daily Target ETF

The community is actively trading the high volatility of $MSTZ, with many traders sharing their success in utilizing it as a tactical hedge or scalp against the price action of $MSTR and broader crypto market movements. Discussions highlight a split between those treating the asset as a quick day-trading instrument to capitalize on intraday pullbacks and those holding longer-term positions, while others debate the inherent risks of leveraged products in a volatile sector.

Netskope, Inc. engages in the provision of cloud based security solutions. It offers business developing analytics for visibility, policy enforcement and other cloud solutions. Its products include Netskope one SASE, Netskope one SSE, cloud access security broker, next generation secure web gateway, private access, cloud firewall, SD-WAN and skopeAI. The company was founded by Sanjay Beri, Lebin Cheng, Ravishankar Ithal, and Krishna Narayanaswamy in October 2012 and is headquartered in Santa Clara, CA.

Netskope Inc. - Ordinary Shares - Class A

Netskope is attracting significant investor interest as it trades near its IPO price, with the community actively discussing potential undervaluation, strong institutional buying, and the company's critical role in AI-native cybersecurity. Despite recent price volatility and concerns surrounding lock-up expiration, many traders view the stock as a long-term acquisition target, emphasizing its solid fundamentals and growing market share in the SASE sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates

CERVOMED INC (CRVO) delivered earnings and revenue surprises of -10.93% and -98.06%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

PHAR heads into Q4 results, with Ruconest and Joenja sales in focus, pipeline updates looming, and investors eyeing clarity on key regulatory setbacks.

CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of "Moderate Buy" by Analysts

Shares of CervoMed Inc. (NASDAQ:CRVO - Get Free Report) have earned an average rating of "Moderate Buy" from the ten research firms that are covering the company, Marketbeat reports. One equities...

CervoMed Inc. (NASDAQ:CRVO) Given Average Rating of "Moderate Buy" by Brokerages

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eleven research firms that are covering the firm, MarketBeat.com reports. Two analysts...

CervoMed Inc. (NASDAQ:CRVO) Receives Average Recommendation of "Moderate Buy" from Brokerages

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eleven analysts that are covering the company, MarketBeat.com reports. Three equities...

Matthew Winton Buys 1,500 Shares of CervoMed (NASDAQ:CRVO) Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) insider Matthew Winton purchased 1,500 shares of the company's stock in a transaction dated Tuesday, November 18th. The shares were bought at an average...

Insider Buying: CervoMed (NASDAQ:CRVO) CEO Buys 1,707 Shares of Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) CEO John Alam acquired 1,707 shares of the business's stock in a transaction on Friday, November 14th. The shares were bought at an average price of...

CervoMed (NASDAQ:CRVO) CEO John Alam Buys 4,447 Shares

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) CEO John Alam acquired 4,447 shares of CervoMed stock in a transaction on Thursday, November 13th. The stock was acquired at an average cost of $7.51 per...

CervoMed (NASDAQ:CRVO) Director Sylvie Gregoire Acquires 4,447 Shares

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) Director Sylvie Gregoire bought 4,447 shares of the company's stock in a transaction on Thursday, November 13th. The shares were acquired at an average...

CervoMed (NASDAQ:CRVO) Insider Matthew Winton Buys 10,000 Shares of Stock

CervoMed Inc. (NASDAQ:CRVO - Get Free Report) insider Matthew Winton bought 10,000 shares of the business's stock in a transaction on Friday, November 14th. The stock was bought at an average price...

CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. CervoMed, Inc. was founded in1995 and is headquartered in Boston, MA.

CRVO
CervoMed Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRVO News

CRVOCervoMed Inc